Return to Clinical Update Archives
May 2009 - Volume 3, Issue 05
In this issue...
- Study supports vitamin K's fracture reducing power
- Vitamin K decreases hardening of the arteries
- Mechanism for vitamin E's anti-cancer benefits explained
- Science builds for vitamin K and prostate cancer
- Magnesium reduces blood pressure in hypertensives
SpectraCell News...
- SpectraCell adds vitamin K to its MicroNutrient Test panel.... Read more
CLINICAL UPDATE - Study supports vitamin K's fracture reducing power
High dose supplements of vitamin K are effective for reducing the risk of fractures in postmenopausal women, according to a new review of the 'reliable literature'.
(Nutrition Research, April 2009)
Link to ABSTRACT: High-dose vitamin K supplementation reduces fracture incidence in postmenopausal women: a review of the literature.
CLINICAL UPDATE - Vitamin K decreases hardening of the arteries
Two recent studies conclude that vitamin K intake is associated with coronary artery calcification
(American Journal of Clinical Nutrition, June 2009)
Link to ABSTRACT: Vitamin K supplementation and progression of coronary artery calcium in older men and women.
Link to ABSTRACT: High dietary menaquinone intake is associated with reduced coronary artery calcification
CLINICAL UPDATE - Mechanism for vitamin E's anti-cancer benefit explained
Tocotrienols, members of the vitamin E family, may exert their anti-cancer benefits by accumulating in cancer cells and delaying tumor growth, says a new study from Japan
(Journal of Nutritional Biochemistry, June 2009)
Link to ABSTRACT: Specific accumulation of gamma- and delta-tocotrienols in tumor and their antitumor effect in vivo.
CLINICAL UPDATE - Science builds for vitamin K and prostate cancer
An improved vitamin K status may reduce the risk of prostate cancer, suggests results from German scientists that build the science linking the vitamin to improved prostate health.
(Cancer Epidemiology, Biomarkers & Prevention, January 2009)
(American Journal of Clinical Nutrition, April 2008)
Link to ABSTRACT: Serum undercarboxylated osteocalcin as biomarker for vitamin K intake and risk of prostate cancer: a nestedk case-control study in the Heidelberg cohort of the European prospective investigation into cancer and nutrition.
Link to ABSTRACT: Dietary intake of vitamin K and risk of prostate cancer in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Heidelberg).
CLINICAL UPDATE - Magnesium reduces blood pressure in hypertensives
Supplemental magnesium may reduce blood pressure in people with high blood pressure, but seemingly normal magnesium levels, says a new study from Korea.
(Nutrition, Metabolism and Cardiovascular Diseases, January 2009)
Link to ABSTRACT: Effects of oral magnesium supplementation on insulin sensitivity and blood pressure in normo-magnesemic nondiabetic overweight Korean adults.
